Abstract
Introduction
Arachidonic acid (AA)-derived prostaglandins recently have been implicated in pathogenesis of hepatocellular carcinoma (HCC). However, current understanding of omega-6-derived oxylipins that promote this disease remains limited, particularly on oxylipins derived from linoleic acid (LA).
Objective
Hepatitis B virus (HBV) infection is a major risk factor for HCC in Asia, we thus quantified AA- and LA-derived oxylipins and the two parent polyunsaturated fatty acids in HBV-related HCC patients to assist in understanding of the molecular pathogenesis of HCC.
Methods
Serum samples from 40 HBV-related HCC patients and 23 age-sex matched healthy controls were analyzed using liquid chromatography tandem mass spectrometry.
Results
LA, LA-derived oxylipins such as 9-hydroxyoctadecadienoic acid (9-HODE), 13-HODE, 9,10-dihydroxyoctadecenoic acid (9,10-DiHOME), and 12,13-DiHOME, as well as AA-derived oxylipins such as 5,6-dihydroxyeicosatrienoic acid (5,6-DiHETrE), 11,12-DiHETrE, and 14,15-DiHETrE, were significantly elevated in HCC patients compared to healthy controls. Of these, LA, 13-HODE, and 9-HODE showed good potential in differentiating HCC patients from healthy controls (AUC >0.8).
Conclusion
The study demonstrated LA- and AA-derived oxylipins via the lipoxygenase and cytochrome P450 pathways appeared to be most involved in the pathogenesis of HBV-related HCC.
References
Avis, I., Martínez, A., Tauler, J., Zudaire, E., Mayburd, A., Abu-Ghazaleh, R., et al. (2005). Inhibitors of the arachidonic acid pathway and peroxisome proliferator–activated receptor ligands have superadditive effects on lung cancer growth inhibition. Cancer Research, 65(10), 4181–4190.
Bae, S. H., Jung, E. S., Park, Y. M., Kim, B. S., Kim, B. K., Kim, D. G., et al. (2001). Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clinical Cancer Research, 7(5), 1410–1418.
Bertomeu, M., Gallo, S., Lauri, D., Haas, T., Orr, F. W., Bastida, E., et al. (1993). Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: Role of vessel wall 13-HODE synthesis and integrin expression. Clinical & Experimental Metastasis, 11(3), 243–250.
Brown, M., Roulson, J. A., Hart, C. A., Tawadros, T., & Clarke, N. W. (2014). Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer. British Journal of Cancer, 110(8), 2099–2108.
Dennis, E. A., & Norris, P. C. (2015). Eicosanoid storm in infection and inflammation. Nature Reviews Immunology, 15(8), 511–523.
Feldstein, A. E., Lopez, R., Tamimi, T. A., Yerian, L., Chung, Y. M., Berk, M., et al. (2010). Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Journal of Lipid Research, 51(10), 3046–3054.
Ghosh, J., & Myers, C. E. (1997). Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochemical and Biophysical Research Communications, 235(2), 418–423.
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., et al. (2015). Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Journal of Lipid Research, 56(3), 722–736.
Lee, Y. H., Cui, L., Fang, J., Chern, B. S., Tan, H. H., & Chan, J. K. (2016). Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis—a targeted ‘omics study. Scientific Reports, 6, 26117.
Leng, J., Han, C., Demetris, A. J., Michalopoulos, G. K., & Wu, T. (2003). Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through AKT activation: evidence for AKT inhibition in celecoxib-induced apoptosis. Hepatology (Baltimore, Md.), 38(3), 756–768.
Lu, Y. H., Huang, C., Gao, L., Xu, Y. J., Chia, S. E., Chen, S. S., et al. (2015). Identification of serum biomarkers associated with hepatitis B virus-related hepatocellular carcinoma and liver cirrhosis using mass-spectrometry-based metabolomics. Metabolomics, 11(6), 1526–1538.
Pasqualini, M., Heyd, V., Manzo, P., & Eynard, A. (2003). Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE:15-HETE ratio. A possible role of their metastatic potential. Prostaglandins, Leukotrienes and Essential Fatty Acids, 68(1), 9–16.
Sauer, L. A., Dauchy, R. T., Blask, D. E., Armstrong, B. J., & Scalici, S. (1999). 13-hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Cancer Research, 59(18), 4688–4692.
Shan, C., Xu, F., Zhang, S., You, J., You, X., Qiu, L., et al. (2010). Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Research, 20(5), 563–575.
Strassburg, K., Huijbrechts, A. M., Kortekaas, K. A., Lindeman, J. H., Pedersen, T. L., Dane, A., et al. (2012). Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: Application in cardiac surgery. Analytical and Bioanalytical Chemistry, 404(5), 1413–1426.
Sun, Y., Koh, H. W., Choi, H., Koh, W. P., Yuan, J. M., Newman, J. W., et al. (2016). Plasma fatty acids, oxylipins, and risk of myocardial infarction: The Singapore Chinese Health Study. Journal of Lipid Research, 57(7), 1300–1307.
Wang, D., & DuBois, R. N. (2010). Eicosanoids and cancer. Nature Reviews Cancer, 10(3), 181–193.
Xu, Y.-J., Ho, W. E., Xu, F., Wen, T., & Ong, C. N. (2013). Exploratory investigation reveals parallel alteration of plasma fatty acids and eicosanoids in coronary artery disease patients. Prostaglandins & Other Lipid Mediators, 106(0), 29–36.
You, X., Liu, F., Zhang, T., Li, Y., Ye, L., & Zhang, X. (2013). Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis, 34(7), 1644–1652.
Zhang, X., You, X., Wang, Q., Zhang, T., Du, Y., Lv, N., et al. (2012). Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-kappaB, 5-LOX, OPN and Capn4 to promote cell migration. PLoS One, 7(2), e31458.
Acknowledgements
We thank all participants for their invaluable contribution to the study.
Funding
This study was partially supported by the Grant of Natural Science Fund of The Science and Technology Commission of Shanghai, China (12ZR1404300), Science and Technology Commission of Shanghai Municipality (16,411,954,300), NUS secondment Funds to CNO (706-000-005-133) and NUS Environmental Research Institute (NERI) (608-000-007-731). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Yonghai Lu and Jinling Fang have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lu, Y., Fang, J., Ong, C.N. et al. Targeted analysis of omega-6-derived oxylipins and parent polyunsaturated fatty acids in serum of hepatitis B virus-related hepatocellular carcinoma patients. Metabolomics 13, 6 (2017). https://doi.org/10.1007/s11306-016-1148-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-016-1148-9